Female Patients With Myofascial Pain Syndrome (MPS) Related to Upper Trapezius Active Trigger Points (TP)
Conditions
Keywords
Myofascial pain syndrome, kinesiotaping, upper trapezius, home exercise program
Brief summary
To investigate the effectiveness of muscle inhibition and space correction techniques of kinesiotaping (KT) method; on pain, functional status and quality of life in female patients with myofascial pain syndrome (MPS) related to upper trapezius active trigger points (TP) in comparison to control group and to determine the advantage of each technique over another.
Detailed description
The investigators conducted a prospective, randomized, controlled trial involving 93 female patients with MPS related to upper trapezius TPs and randomized the patients to KT treatment group with space correction technique and home exercise program (KSCT, n=20), KT treatment group with muscle inhibition technique and home exercise program (KMIT, n=24) and control group (CG, n=27) which received home exercise program only. Patients were evaluated by numerical rating scale (NRS) for their average and maximum pain intensity, Turkish version of neck disability index (NDI), and short form-36 (SF-36) scales. Statistical tests were conducted at the 0.05 significance level for all outcome measures.
Interventions
OTHERKinesiotaping with space correction technique
Kinesiotaping with space correction technique twice per week for two weeks along with home exercise program
OTHERKinesiotaping with muscle inhibition technique
Kinesiotaping with muscle inhibition technique twice per week for two weeks along with home exercise program
OTHERHome exercise program
Home exercise program which consists of stretching exercises towards neck area
Sponsors
Dilşad Sindel
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No
Inclusion criteria
* being female * being aged between 18 and 45 years old * not being in menopausal period * having pain in upper trapezius region * determining a taut band in examination * having at least one active TP in this taut band * the pain produced by palpation of this TP is the pain that the patient complains * painfull restriction of cervical lateral flexion * having pain score 4 or more according to NRS * signing informed consent.
Exclusion criteria
* having major surgery or trauma related to the musculoskeletal system (primarily including the spine and upper extremity) * having any operative history including the head and neck region * having a neuromuscular disease * having an active rheumatic disease * having a systemic disease (diabetes, hypothyroidism, infection, malignancy...) * having any pathology related to musculoskeletal diseases -especially including the cervical region- (cervical discopathy, cervical spondylosis, pathologies related to shoulder joint and surrounding soft tissues, scoliosis, kyphosis, limb length discrepancy, polio sequelae, developmental hip dysplasia...) * having serious psychological problems (having score of 30 or more from Beck Depression Inventory) * being obese (Body Mass Index≥30 kg/m2) * having allergy to kinesiotapes
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in pain related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to first, second and six weeks | Initial assessment, First week, second week, sixth week | Pain intensity mesaurement via Numerical Rating Scale, range between 0 to 10, higher scores indicating more pain intensity |
| Change in disability related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks | Initial assessment, second week, sixth week | Functional status measurement via Neck Disability Index |
| Change in quality of life affected by myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks | Initial assessment, second week, sixth week | Quality of life measurement via Short Form-36 |
Outcome results
None listed